Effects of dopamine antagonists in human eye accommodation
1Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Republic of China.
Summary
Dopamine antagonists like metoclopramide and droperidol may affect the rate of eye accommodation but not its overall degree. Further research is needed to determine the exact efficacy of these drugs.
Area of Science:
- Ophthalmology
- Neuropharmacology
Background:
- Dopamine plays a role in ocular functions.
- Understanding the impact of dopamine antagonists on visual accommodation is crucial for potential therapeutic applications.
Purpose of the Study:
- To investigate the effects of topical dopamine antagonists, specifically metoclopramide and droperidol, on human eye accommodation.
- To evaluate parameters including reaction latency, accommodation rate, average power, and recovery time.
Main Methods:
- A double-masked, placebo-controlled study involving 18 healthy subjects.
- Topical administration of 0.5% metoclopramide or 0.25% droperidol in one eye, with saline in the fellow eye.
- Measurement of accommodative abilities at baseline, 3 hours, and 6 hours post-instillation.
Main Results:
- Significant changes were observed in the rate of accommodation and the rate of recovery.
- No significant alterations were found in accommodation latency, average accommodative power, or total recovery time.
- The study suggests dopamine antagonists influence the speed of accommodation rather than its extent.
Conclusions:
- Dopamine antagonists may modulate the dynamics of ocular accommodation.
- Further dose-response studies with higher concentrations are necessary to establish definitive drug efficacy.
- The findings provide preliminary insights into the neuropharmacological control of accommodation.
Related Concept Videos
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...